Linezolid Teva

Linezolid, the active ingredient in Linezolid Teva, is an oxazolidinone presented as an oral tablet for oral use. It treats a range of Gram‑positive bacterial infections, including methicillin‑resistant Staphylococcus aureus (MRSA), community‑acquired pneumonia, and skin and soft‑tissue infections in adult patients.

GNH USA supplies Linezolid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid Teva is an oxazolidinone antibiotic used to manage infections caused by susceptible Gram‑positive bacteria.

- Gram‑positive bacterial infections: reduces bacterial load and resolves infection symptoms. - Methicillin‑resistant Staphylococcus aureus (MRSA): provides effective oral therapy for resistant strains. - Community‑acquired pneumonia: treats pneumonia caused by susceptible organisms. - Skin and soft‑tissue infections: clears infection and promotes healing of affected tissues.

Linezolid may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Metallic taste: persistent metallic sensation in the mouth. - Vomiting: occasional emesis. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: tingling or numbness in extremities. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuropathy: vision changes requiring prompt evaluation.

When prescribing Linezolid, clinicians should consider several safety measures.

- Monitor blood counts: watch for thrombocytopenia and anemia. - Assess renal and hepatic function: adjust therapy if impairment is present. - Avoid serotonergic drugs: risk of serotonin syndrome. - Use caution in patients with prior myelosuppression: increased risk of hematologic effects. - Adjust dose in severe renal impairment: follow prescribing guidelines. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): can precipitate hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants): risk of serotonin syndrome. - Rifampin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive bleeding tendency. - Digoxin: potential increase in serum levels requiring monitoring.